Detalhe da pesquisa
1.
Amount of Testosterone on Laundered Clothing After Use of Testosterone Topical 2% Solution by Healthy Male Volunteers.
J Sex Med
; 13(2): 187-93, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26803453
2.
Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib.
Eur J Clin Pharmacol
; 72(5): 563-72, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26857125
3.
Absolute bioavailability of evacetrapib in healthy subjects determined by simultaneous administration of oral evacetrapib and intravenous [(13) C8 ]-evacetrapib as a tracer.
J Labelled Comp Radiopharm
; 59(6): 238-44, 2016 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26639670
4.
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study.
J Pediatr Hematol Oncol
; 37(1): 1-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25493452
5.
Effect of deodorant and antiperspirant use and presence or absence of axillary hair on absorption of testosterone 2% solution applied to men's axillae.
J Sex Med
; 11(11): 2809-17, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25123988
6.
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients.
J Thromb Thrombolysis
; 38(2): 127-36, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24043374
7.
A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity.
Br J Clin Pharmacol
; 75(6): 1433-44, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23171128
8.
Pharmacokinetic and pharmacodynamic effects of prasugrel in healthy Korean males.
J Cardiovasc Pharmacol
; 62(1): 72-7, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23594968
9.
Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.
Br J Clin Pharmacol
; 73(1): 93-105, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21689142
10.
The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data.
J Cardiovasc Pharmacol
; 57(3): 317-24, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21266916
11.
A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis.
J Cardiovasc Pharmacol
; 56(1): 29-37, 2010 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20386460
12.
The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects.
Eur J Clin Pharmacol
; 66(2): 127-35, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19888568
13.
Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38.
J Clin Pharmacol
; 49(8): 984-98, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19546250
14.
Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjects.
Platelets
; 20(5): 316-27, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19637095
15.
A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
Thromb Haemost
; 99(1): 215-22, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18217157
16.
The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration.
Thromb Haemost
; 99(2): 409-15, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18278193
17.
Prasugrel, a new thienopyridine antiplatelet drug, weakly inhibits cytochrome P450 2B6 in humans.
J Clin Pharmacol
; 48(1): 53-9, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18094219
18.
Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
J Clin Pharmacol
; 48(4): 475-84, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18303127
19.
Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.
Pharmacotherapy
; 28(12): 1483-94, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19025429
20.
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects.
Platelets
; 19(4): 275-81, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18569863